Who is sponsoring NCT04214795?

NCT04214795 is sponsored by Hospital General Universitario Gregorio Marañon.

What drugs are being tested in NCT04214795?

Interventions in NCT04214795: Observational study. Postnatal variables are recorded.

What condition does NCT04214795 study?

NCT04214795 studies Morbidity;Newborn.

Is NCT04214795 still recruiting?

NCT04214795 is currently status unknown. Last updated 2 January 2020.

Last reviewed 2020-01-02 · How we verify

NCT04214795

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Antenatal Steroids Effect on Mortality and Respiratory Outcomes in Preterm Infants

Status unknown Last updated 2 January 2020

What this trial tests

trial testing Observational study. Postnatal variables are recorded in Morbidity;Newborn in 710 participants. Status unknown.

Timeline

1 January 2012

Primary endpoint
31 December 2018

31 December 2020

Quick facts

Lead sponsor	Hospital General Universitario Gregorio Marañon
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	710
Start date	1 January 2012
Primary completion	31 December 2018
Estimated completion	31 December 2020
Sites	1 location across Spain

Drugs / interventions tested

Observational study. Postnatal variables are recorded

Conditions studied

Morbidity;Newborn — all drugs for Morbidity;Newborn →

Sponsor

Hospital General Universitario Gregorio Marañon

Who can join

Under 6 Hours, any sex, with Morbidity;Newborn. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to evaluate the impact of a complete course of antenatal steroids treatment on mortality and main morbidities in a current population of preterm infants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Morbidity;Newborn

Currently open trials in the same condition.

NCT06087224 — The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals · NA · recruiting

Other Hospital General Universitario Gregorio Marañon trials

Trials by the same sponsor.

NCT07537517 — Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension. · recruiting
NCT07229040 — A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patient · Phase 2 · recruiting
NCT06998862 — Colchicine in Chronic Kidney Disease Patients · Phase 3 · recruiting
NCT05853081 — FODEPOC Study: Fat-free Mass Index in Copd · unknown
NCT06052436 — Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04214795 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital General Universitario Gregorio Marañon
Last refreshed: 2 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04214795.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing